ALPS Group Inc Ordinary Share (ALPS) carries a Roarable Rating of D+ (Sell) with 57/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
As of 2026-11-01, ALPS Group Inc Ordinary Share (NASDAQ: ALPS) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 57/100 at a spot price of $0.32 (-0.03% 1D, market cap $54.1M). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 13/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 10/20, and SEC Balance-Sheet Forensics 9/20. Across 1016 tracked Health Care issuers, ALPS ranks #258 in composite RQD confidence.
Within the Health Care sector (Medical/Nursing Services), ALPS carries a Roarable D+ (57/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of —. By comparison, EUDA (EUDA Health Holdings Limited) holds a D- grade (39/100 RQD, P/E N/A, ROIC -35.0%, cap $46.4M) and BMGL (Basel Medical Group Ltd) posts a D+ grade (58/100 RQD, P/E N/A, ROIC —, cap $36.0M). Among the 5-stock peer group, ALPS leads on earnings multiple (N/A) while EUDA leads on capital efficiency (-35.0% ROIC).
For ALPS Group Inc Ordinary Share (ALPS), key quantitative strengths include Established market leader in Health Care with deep daily trading liquidity. and sector rank #258 in Health Care, while primary risk factors center on Company executives have done more routine share selling than personal cash buying lately. and Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
20D Institutional Volume Accumulation (±10.2% realized swing band)
Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 7/9
Disciplined Float (-0.40% YoY Shares) & executive Form 4 sales trim 11 pts from alignment
Even with a 57/100 (D+) score, ALPS faces multiple-compression risk if current valuation multiples re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.
Company executives have done more routine share selling than personal cash buying lately.
Sensitive to high interest rates and tighter Federal Reserve market liquidity.
Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($0.37) or 200D SMA ($0.68) invalidates the momentum regime and cuts Target Base ($0.32) toward Bear Floor ($0.25).
ALPS Group Inc Ordinary Share (ALPS) slipped -0.03% to $0.32, trading at 6% of its 52-week range ($0.23 – $1.75). Stretched risk/reward at current multiples (steady margins) under elevated 10-year interest-rate pressure.
KUALA LUMPUR, Malaysia, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Alps Group Inc (“Alps” or “the Company”) (Nasdaq: ALPS), an integrated biotechnology platform headquartered in Malaysia, today announced that its shareholders app
Alps Group Inc ("Alps" or "the Company") (NASDAQ:ALPS), an integrated biotechnology platform headquartered in Malaysia, today announced that its shareholders approved, in accordance with Cayman Islands
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on ALPS today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for ALPS. Explore sector supply chains on /butterfly.
Across 1016 tracked Health Care securities in the Roarable RQD universe, ALPS Group Inc Ordinary Share (ALPS) ranks #258 by composite RQD confidence (57/100, grade D+) and #739 by equity capitalization ($54.1M). Within this direct 5-issuer industry benchmark cohort, ALPS leads on earnings valuation at N/A trailing P/E, while EUDA leads on capital efficiency and profitability with -35.0% ROIC and 43.9% gross margin. BMGL currently holds the highest overall quantitative score in the immediate peer group at 58/100 (D+) compared with ALPS at 57/100 (D+).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| ALPS
ACTIVE
ALPS Group Inc Ordinary Share | D+ | 57/100 | — | — | — | -0.03% | $54.1M | Benchmark Subject |
| EUDA EUDA Health Holdings Limited | D- | 39/100 | — | 43.9% | -35.0% | +1.31% | $46.4M | /euda-vs-alps → |
| BMGL Basel Medical Group Ltd | D+ | 58/100 | — | — | — | +3.26% | $36.0M | /bmgl-vs-alps → |
| PIII P3 Health Partners Inc. (Class A) | D- | 38/100 | — | — | -35.0% | +4.22% | $30.5M | /piii-vs-alps → |
| DCGO DocGo Inc. | D- | 43/100 | — | — | -35.0% | -2.43% | $27.0M | /dcgo-vs-alps → |
ALPS Group Inc Ordinary Share (ALPS) operates in Medical/Nursing Services (Health Care) with an equity capitalization of $54.1M, trailing P/E of N/A, forward P/E of N/A, and EV/EBITDA of N/A. Operating profitability registers a gross margin of —, operating margin of —, net profit margin of —, ROIC of —, and free cash flow yield of —, alongside an Altman Z-Score of N/A and Piotroski F-Score of N/A.
As of 2026-11-01, ALPS Group Inc Ordinary Share (NASDAQ: ALPS) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 57/100 at a spot price of $0.32 (-0.03% 1D, market cap $54.1M). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 13/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 10/20, and SEC Balance-Sheet Forensics 9/20. Across 1016 tracked Health Care issuers, ALPS ranks #258 in composite RQD confidence.
Within the Health Care sector (Medical/Nursing Services), ALPS carries a Roarable D+ (57/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of —. By comparison, EUDA (EUDA Health Holdings Limited) holds a D- grade (39/100 RQD, P/E N/A, ROIC -35.0%, cap $46.4M) and BMGL (Basel Medical Group Ltd) posts a D+ grade (58/100 RQD, P/E N/A, ROIC —, cap $36.0M). Among the 5-stock peer group, ALPS leads on earnings multiple (N/A) while EUDA leads on capital efficiency (-35.0% ROIC).
For ALPS Group Inc Ordinary Share (ALPS), key quantitative strengths include Established market leader in Health Care with deep daily trading liquidity. and sector rank #258 in Health Care, while primary risk factors center on Company executives have done more routine share selling than personal cash buying lately. and Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.
ALPS last traded at $0.32 (-0.03% on volume of 28,769 shares), positioning the stock -13.51% below its 50-day simple moving average ($0.37) and -52.94% below its 200-day simple moving average ($0.68). Across its 52-week range of $0.23 to $1.75, ALPS sits at the 5.9% percentile with a 14-day RSI of 27.4 (OVERSOLD (<32)) and an implied next-earnings move of ±10.2% ($1.00 to $0.35).
Why ALPS Stock Traded Steady Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (steady margins) under elevated 10-year interest-rate pressure.
To protect compute speed and zero-delay Cboe BZX data quality for active members, our current $9.95/month Roarable Pro cohort is 100% full. Join the priority waiting list below and we will notify you the moment the next batch of Pro accounts opens (and lock in your $9.95/mo rate).
Link your personal ChatGPT, Claude Desktop, or Cursor via Roarable's Model Context Protocol (`mcp.roarable.com`) to query all 5,289 stocks, inspect Butterfly supply chains, and trade your `$100K Arena` account.
Interrogate SEC 10-K/10-Q filings on demand and ask custom ticker, valuation, or short-thesis questions directly to any of our 8 specialized AI Quant Analysts.
Command our AI agents to sort and sift 5,289 stocks by custom formulas, follow multi-indicator technical & cash-flow setups, and send you instant Email/SMS breakout & downgrade alerts.
Unlock sub-second Cboe BZX streaming quotes, pre-market/after-hours delta scanners, instant SEC Form 4 insider cluster alerts, and unlimited portfolio stress-testing.
All 8 Roarable Analysts (Mara Quenwick, Devon Kess, Gideon Vane, Eliott Vance, Sorel Thorne, Corin Hale, Tessa Rane, and Felix Orven) are proprietary AI Quant Analysts and automated algorithmic specialists — not human financial advisors, fiduciaries, or registered broker-dealers. While one-to-many daily stock ratings and briefings are free, custom 1-on-1 Q&A, custom AI sifting/indicator alert agents, and personal ChatGPT/Claude MCP connections consume dedicated per-user compute and require a $9.95/month Roarable Pro membership. All AI outputs are for educational and research purposes only and never constitute individualized investment advice.
Enter your Google email below for instant 1-step account activation, daily A–E stock rating alerts, and immediate access to your $100,000.00 Paper Trading Arena account.